Deutsche Bank’s Trinity Biotech TRIB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q4 | – | Sell |
-1,496
| Closed | -$9K | – | 4810 |
|
2019
Q3 | $9K | Sell |
1,496
-11,544
| -89% | -$69.4K | ﹤0.01% | 4300 |
|
2019
Q2 | $107K | Buy |
13,040
+4,740
| +57% | +$38.9K | ﹤0.01% | 4048 |
|
2019
Q1 | $118K | Sell |
8,300
-920
| -10% | -$13.1K | ﹤0.01% | 4108 |
|
2018
Q4 | $105K | Sell |
9,220
-8,776
| -49% | -$99.9K | ﹤0.01% | 4054 |
|
2018
Q3 | $360K | Buy |
17,996
+1,138
| +7% | +$22.8K | ﹤0.01% | 3890 |
|
2018
Q2 | $421K | Buy |
16,858
+4,704
| +39% | +$117K | ﹤0.01% | 3861 |
|
2018
Q1 | $312K | Buy |
12,154
+4,215
| +53% | +$108K | ﹤0.01% | 3876 |
|
2017
Q4 | $202K | Buy |
+7,939
| New | +$202K | ﹤0.01% | 3864 |
|
2017
Q3 | – | Hold |
0
| – | – | – | 4498 |
|
2017
Q2 | – | Hold |
0
| – | – | – | 4567 |
|
2017
Q1 | – | Sell |
-143
| Closed | -$4K | – | 4534 |
|
2016
Q4 | $4K | Sell |
143
-6,607
| -98% | -$185K | ﹤0.01% | 4340 |
|
2016
Q3 | $446K | Buy |
6,750
+6,568
| +3,609% | +$434K | ﹤0.01% | 3172 |
|
2016
Q2 | $10K | Sell |
182
-4,130
| -96% | -$227K | ﹤0.01% | 4543 |
|
2016
Q1 | $251K | Buy |
4,312
+4,293
| +22,595% | +$250K | ﹤0.01% | 3455 |
|
2015
Q4 | $1K | Sell |
19
-19,236
| -100% | -$1.01M | ﹤0.01% | 4684 |
|
2015
Q3 | $1.1M | Buy |
19,255
+9,377
| +95% | +$536K | ﹤0.01% | 2839 |
|
2015
Q2 | $890K | Buy |
9,878
+4,910
| +99% | +$442K | ﹤0.01% | 2989 |
|
2015
Q1 | $477K | Sell |
4,968
-140
| -3% | -$13.4K | ﹤0.01% | 3239 |
|
2014
Q4 | $446K | Buy |
5,108
+1,812
| +55% | +$158K | ﹤0.01% | 3621 |
|
2014
Q3 | $301K | Sell |
3,296
-227
| -6% | -$20.7K | ﹤0.01% | 3683 |
|
2014
Q2 | $405K | Buy |
3,523
+1,231
| +54% | +$142K | ﹤0.01% | 3511 |
|
2014
Q1 | $277K | Buy |
2,292
+1,892
| +473% | +$229K | ﹤0.01% | 3708 |
|
2013
Q4 | $50K | Sell |
400
-419
| -51% | -$52.4K | ﹤0.01% | 4306 |
|
2013
Q3 | $88K | Sell |
819
-3,210
| -80% | -$345K | ﹤0.01% | 4455 |
|
2013
Q2 | $339K | Buy |
+4,029
| New | +$339K | ﹤0.01% | 3413 |
|